SPONSOR
Qilu Pharmaceutical Co., Ltd.
Total Trials
5
Recruiting
5
Phases
Phase 3, Phase 1, Phase 2, Phase 1
Conditions studied: Heavy Menstrual BleedingUterine FibroidsAdvanced Prostate CancerCarcinoma, Non-Small-Cell LungAtopic DermatitisAdvanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Heavy Menstrual Bleeding, Uterine Fibroids, Advanced Prostate Cancer, Carcinoma, Non-Small-Cell Lung.
The trial portfolio spans Phase 3, Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Qilu Pharmaceutical Co., Ltd.
How many clinical trials has Qilu Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Qilu Pharmaceutical Co., Ltd., of which 5 are actively recruiting participants. These trials cover conditions including Heavy Menstrual Bleeding, Uterine Fibroids, Advanced Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Qilu Pharmaceutical Co., Ltd. research focus on?
Qilu Pharmaceutical Co., Ltd. clinical trials span Heavy Menstrual Bleeding, Uterine Fibroids, Advanced Prostate Cancer, Carcinoma, Non-Small-Cell Lung, Atopic Dermatitis, and additional conditions. The research pipeline includes Phase 3, Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Qilu Pharmaceutical Co., Ltd. clinical trial?
To participate in a Qilu Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Qilu Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Qilu Pharmaceutical Co., Ltd.
NCT06671548 Phase 3
Recruiting
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Heavy Menstrual Bleeding
NCT07198633 Phase 1, Phase 2
Recruiting
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
Advanced Prostate Cancer
NCT05487391 Phase 3
Recruiting
A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
Carcinoma, Non-Small-Cell Lung
NCT06880276 Phase 3
Recruiting
Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
Atopic Dermatitis
NCT05823285 Phase 1
Recruiting
A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients
Advanced Solid Tumors
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology